HIPK4 Antibody

What is HIPK4 and why is it significant in research?

HIPK4 (Homeodomain-interacting protein kinase 4) is a serine/threonine kinase that belongs to the HIPK family of proteins. Unlike its family members HIPK1-3, HIPK4 is smaller and has distinct structural features, primarily containing a catalytic domain at its N-terminal end . HIPK4 has gained significant research interest due to its tissue-specific expression pattern and essential role in spermiogenesis.

HIPK4 is predominantly expressed in the testis, specifically in round and early elongating spermatids during stages 3-8 of spermatid development . Knockout studies in mice have demonstrated that HIPK4 is essential for proper sperm head shaping and male fertility, making it a crucial target for reproductive biology research . HIPK4-null mice exhibit phenotypes consistent with oligoasthenoteratozoospermia (reduced sperm number, motility, and abnormal morphology), and the sperm produced by these mice have reduced oocyte binding capacity and are incompetent for in vitro fertilization .

What are the optimal sample types for HIPK4 detection?

Based on the tissue distribution data, testicular tissue is the optimal sample type for HIPK4 detection, as HIPK4 is predominantly expressed in the testis . For human samples, testicular biopsies would be most appropriate. In mouse models, whole testis extraction or dissociated testicular cells can be used.

For cellular studies, isolated round and early elongating spermatids (steps 3-8) are ideal, as HIPK4 shows cytoplasmic localization in these specific cell types . When working with cell lines, those derived from testicular tissue would be most appropriate, though overexpression systems in HEK293T cells have also been successfully used to study HIPK4 function .

What methods can be used to detect endogenous HIPK4 expression?

Multiple methods can be employed to detect endogenous HIPK4:

• Western blotting: Effective for detecting HIPK4 protein in testis lysates using commercially available antibodies. Note that endogenous HIPK4 typically migrates at a higher molecular weight than predicted (69.425 kDa), likely due to post-translational modifications . Validated antibodies include polyclonal anti-HIPK4 (Abgent) and laboratory-generated antibodies as described in the literature .

• Immunohistochemistry/Immunofluorescence: Useful for localizing HIPK4 in testis sections or isolated germ cells. HIPK4 shows cytoplasmic distribution in round and early elongating spermatids (steps 3-8) .

• In situ hybridization: For detecting HIPK4 mRNA in tissue sections. The RNAscope 2.5 HD Detection Kit with specific HIPK4 probes (Mm-Hipk4, 428071) has been successfully used for this purpose .

• RT-PCR: TaqMan primers (Mm01156517_g1) can be used to quantify HIPK4 expression relative to housekeeping genes like GAPDH (Mm99999915_g1) .

How should western blotting protocols be optimized for HIPK4 detection?

For optimal western blot detection of HIPK4, follow these methodological guidelines:

• Sample preparation: Prepare testis lysates by sonication in ice-cold RIPA buffer containing protease inhibitors (cOmplete, EDTA-free Protease Inhibitor Cocktail) and phosphatase inhibitors (PhosSTOP) . This is critical as HIPK4 is subject to post-translational modifications.

• Protein separation: Use 3-8% tris-acetate gels for optimal separation. Load approximately 12 μg of total protein per sample .

• Antibody selection: Use validated anti-HIPK4 antibodies at appropriate dilutions. For polyclonal antibodies, a 1:500-1:3000 dilution range is recommended for western blotting .

• Detection system: Use HRP-conjugated secondary antibodies (1:20,000) and either SuperSignal West Dura or SuperSignal Femto kits for chemiluminescence detection .

• Controls: Include positive controls (testis tissue from wild-type animals) and negative controls (HIPK4 knockout tissue if available) to validate specificity.

• Migration patterns: Be aware that endogenous HIPK4 often migrates at a higher molecular weight than predicted due to post-translational modifications, particularly phosphorylation and potentially sumoylation .

What are the critical parameters for immunohistochemical detection of HIPK4?

For successful immunohistochemical detection of HIPK4:

• Fixation: Use freshly prepared modified Davidson's fixative (30% formaldehyde, 15% ethanol, 5% glacial acetic acid, 50% distilled water) for 16-20 hours, followed by washing and storage in 70% ethanol .

• Sectioning: For paraffin-embedded tissues, 10 μm sections are recommended .

• Antibody dilution: For immunohistochemistry, use polyclonal anti-HIPK4 antibodies at a dilution of 1:50-1:100 .

• Detection systems: For fluorescence imaging, use appropriate secondary antibodies such as Alexa Fluor 647-conjugated goat anti-rabbit IgG .

• Co-staining markers: Consider co-staining with markers for different stages of spermatogenesis to precisely identify HIPK4-expressing cells.

• Controls: Include appropriate isotype controls and tissues from HIPK4 knockout animals as negative controls.

How can HIPK4 kinase activity be assessed in experimental settings?

To evaluate HIPK4 kinase activity:

• In vitro kinase assays: Express wild-type HIPK4 or kinase-dead mutants (K40A, D136N) in expression systems. The lysine at position 40 and aspartic acid at position 136 within the catalytic domain are critical for HIPK4 kinase activity .

• Phos-tag gel electrophoresis: This technique can be used to detect mobility shifts in HIPK4 substrates due to phosphorylation. When co-expressed with HIPK4, phosphorylated substrates (such as RIMBP3) show altered migration behavior compared to when expressed with kinase-dead HIPK4 mutants (Y175F) .

• Phosphoproteomic analysis: Multiplexed tandem mass tags (TMT) labeling and tandem mass spectrometry (LC-MS/MS) approaches can be used to quantify the proteome and phosphoproteome changes in HIPK4 knockout versus wild-type tissues .

• Co-immunoprecipitation: To identify HIPK4 substrates and interacting partners, immunoprecipitate using anti-HIPK4 antibodies followed by mass spectrometry or western blotting for specific targets .

How do HIPK4 mutations affect spermatogenesis and what techniques can be used to analyze these effects?

HIPK4 mutations profoundly affect spermatogenesis, particularly during spermiogenesis. To analyze these effects:

• Ultrastructural analysis: Transmission electron microscopy (TEM) reveals that HIPK4-null spermatids have abnormalities in the acrosome-acroplaxome complex beginning at step 8-9 of spermiogenesis. The posterior edge of the acrosome is no longer juxtaposed to the perinuclear ring of the manchette, leading to widening of the groove belt and deformation of the underlying nuclear lamina .

• Cytoskeletal analysis: F-actin staining with fluorescently labeled phalloidin shows that HIPK4-null spermatids fail to maintain F-actin at later stages of differentiation. Anti-β-actin staining reveals fragmented acrosomes and defects in the underlying acroplaxome .

• Functional assays: HIPK4-null sperm show reduced oocyte binding capacity and are incompetent for in vitro fertilization, though they can still produce viable offspring via intracytoplasmic sperm injection (ICSI) .

• Molecular interaction studies: HIPK4 has been shown to interact with and phosphorylate RIMS-binding protein 3 (RIMBP3), a manchette-associated protein critical for sperm head shaping . Co-immunoprecipitation and phosphorylation assays can be used to study this interaction.

What are the known substrates of HIPK4 and how can new substrates be identified?

Current research has identified several HIPK4 substrates and potential interacting partners:

• RIMBP3 (RIMS-binding protein 3): A manchette-associated protein that has been confirmed as a phosphorylation substrate of HIPK4. Co-immunoprecipitation experiments show that RIMBP3 interacts with HIPK4 in both testis lysates and in HEK293T cells .

• Actin-interacting proteins: Phosphoproteomic analyses have identified multiple actin-interacting proteins as potential HIPK4 substrates, including talin 1 (TLN1), coronin 1B (CORO1B), A-kinase anchor protein 2 (AKAP2), formin 1 (FMN1), vinculin (VCL), MARCKS, paxillin (PXN), WASH family members (WASL, WIPF1, and FAM21), zyxin (ZYX), unconventional myosin 5a (MYO5a), filamins (FLNA and FLNB), and transgelins (TAGLN and TAGLN3) .

To identify new HIPK4 substrates:

• Phosphoproteomic approaches: Compare phosphorylation patterns in wild-type versus HIPK4 knockout tissues, or in cells expressing wild-type HIPK4 versus kinase-dead mutants (K40A, D136N, or Y175F) .

• Substrate-trapping mutants: Generate substrate-trapping HIPK4 mutants that can bind but not release substrates, followed by immunoprecipitation and mass spectrometry.

• In vitro kinase assays: Test candidate substrates by expressing them with wild-type or kinase-dead HIPK4, followed by detection of phosphorylation using phospho-specific antibodies or Phos-tag gel electrophoresis .

• Co-immunoprecipitation followed by mass spectrometry: Immunoprecipitate HIPK4 from testicular lysates and identify interacting proteins by mass spectrometry .

How does HIPK4 regulate cytoskeletal dynamics and what experimental approaches can be used to study this function?

HIPK4 plays a critical role in regulating cytoskeletal dynamics, particularly F-actin structures. Experimental approaches to study this function include:

• Overexpression systems: When HIPK4 is overexpressed in cultured fibroblasts (NIH-3T3 cells), it induces dramatic changes in cell morphology and F-actin organization. Cells expressing HIPK4 become either spherical or polygonal and multinucleate, with a striking loss of F-actin-containing stress fibers .

• Ultracentrifugation assays: These can be used to determine the ratio of soluble, globular actin (G-actin) to filamentous actin (F-actin) in cells expressing HIPK4 versus controls .

• Fluorescent labeling: Phalloidin staining of F-actin structures in wild-type versus HIPK4 knockout tissues or cells can reveal differences in F-actin organization .

• Phosphoproteomic analysis: This approach can identify changes in the phosphorylation state of actin-interacting proteins upon HIPK4 overexpression or knockout .

• Co-fractionation experiments: HIPK4 has been shown to co-fractionate with F-actin in testis, suggesting a direct or indirect interaction with the actin cytoskeleton .

• Live-cell imaging: Time-lapse microscopy of cells expressing fluorescently tagged actin and HIPK4 can provide insights into the dynamics of cytoskeletal remodeling.

What are common issues with HIPK4 antibody specificity and how can they be addressed?

To ensure antibody specificity when working with HIPK4:

• Validation in knockout tissues: The gold standard for antibody validation is testing in tissues from HIPK4 knockout animals. An absence of signal in knockout tissues confirms specificity .

• Multiple antibody approach: Use different antibodies targeting different epitopes of HIPK4 to confirm consistent results. Both commercially available antibodies (such as from Abgent, San Diego, CA) and laboratory-generated antibodies have been successfully used .

• Blocking peptides: Use specific blocking peptides corresponding to the antibody epitope to confirm signal specificity.

• Western blot validation: Before using antibodies for immunohistochemistry or immunofluorescence, validate them by western blotting using positive control tissues (testis) and negative control tissues (non-expressing tissues or knockout samples).

• Recombinant protein controls: Use purified recombinant HIPK4 as a positive control for western blotting.

• Signal comparison with mRNA expression: Compare antibody staining patterns with mRNA expression patterns as determined by in situ hybridization to ensure consistency.

How can researchers distinguish between HIPK4 and other HIPK family members in experimental systems?

Distinguishing between HIPK family members requires careful experimental design:

• Antibody selection: Use antibodies that target unique regions of HIPK4 that are not conserved in other HIPK family members. The C-terminal region of HIPK4 (amino acids 511-616) is distinctive and can be targeted for specific detection .

• PCR primer design: Design PCR primers that target unique sequences in HIPK4. For qRT-PCR, validated primers like TaqMan Mm01156517_g1 have been used successfully .

• Expression pattern analysis: HIPK4 has a distinct tissue distribution compared to other HIPK family members, being predominantly expressed in the testis. This can help distinguish it in tissue samples .

• Molecular weight discrimination: HIPK4 (69.425 kDa) is smaller than other HIPK family members and has a distinct migration pattern on western blots .

• Knockout controls: Use tissues or cells from HIPK4 knockout models as negative controls to ensure signal specificity.

• Domain-specific functional assays: Design assays that target the unique functional properties of HIPK4 compared to other HIPKs, such as its specific interactions with manchette proteins .

What controls should be included when assessing HIPK4 kinase activity in experimental systems?

When assessing HIPK4 kinase activity, include the following controls:

• Kinase-dead mutants: Include several kinase-dead mutants of HIPK4 as negative controls:

  • K40A: Mutation of the conserved lysine at position 40 in the catalytic domain

  • D136N: Mutation of the conserved aspartic acid at position 136

  • Y175F: Mutation that prevents autophosphorylation-dependent activation

  • Double mutant (K40A/D136N)

• Autophosphorylation control: HIPK4 exhibits autophosphorylation, which can serve as an internal positive control for kinase activity .

• Known substrate controls: Include known substrates of HIPK4, such as RIMBP3, as positive controls for substrate phosphorylation .

• Phosphatase treatment: Treat samples with phosphatases to confirm that the observed mobility shifts or phospho-specific signals are indeed due to phosphorylation.

• Inhibitor controls: Use broad-spectrum kinase inhibitors (such as staurosporine) as well as more selective inhibitors to validate the specificity of the kinase activity.

• ATP-dependence: Perform parallel reactions with and without ATP to confirm that the observed phosphorylation is ATP-dependent, as expected for a kinase.

How might HIPK4 be targeted for male contraceptive development?

HIPK4 presents an intriguing target for male contraceptive development based on several key findings:

Research approaches for HIPK4-targeted contraceptive development:

• Small molecule screening: Develop and screen selective HIPK4 inhibitors using in vitro kinase assays.

• Structure-based drug design: Use the known catalytic domain structure to design specific inhibitors that target the ATP-binding pocket or substrate-binding regions.

• In vivo efficacy testing: Test lead compounds in animal models to assess contraceptive efficacy, reversibility, and safety.

• Genetic validation: Study the effects of conditional or inducible HIPK4 knockout to model the effects of pharmacological inhibition and assess reversibility.

What is the relationship between HIPK4 dysfunction and human male infertility disorders?

The relationship between HIPK4 dysfunction and human male infertility is an emerging area of research:

• Genetic evidence: HIPK4 mutations have been identified in patients with non-obstructive azoospermia (NOA), including a heterozygous truncating mutation that leads to decreased protein expression .

• Phenotypic correlation: The phenotypes observed in HIPK4 knockout mice closely resemble oligoasthenoteratozoospermia (OAT) in humans, a common cause of male infertility characterized by reduced sperm count, motility, and abnormal morphology .

• Molecular mechanisms: HIPK4 regulates key processes in spermiogenesis, including acrosome-acroplaxome complex formation and manchette function, which are essential for proper sperm head shaping .

Research approaches to further investigate this relationship:

• Genetic screening: Screen infertile men, particularly those with OAT, for HIPK4 mutations or expression abnormalities.

• Functional validation: Assess the impact of identified HIPK4 variants on protein function using in vitro kinase assays and cellular models.

• Genotype-phenotype correlations: Correlate specific HIPK4 genetic variants with detailed sperm phenotypes to establish causality.

• Animal models: Generate mouse models carrying human HIPK4 mutations to determine their effects on fertility and sperm development.

What techniques can be used to study the temporal regulation of HIPK4 during spermatogenesis?

To study the temporal regulation of HIPK4 during spermatogenesis:

• Stage-specific isolation: Use techniques such as STA-PUT velocity sedimentation or FACS sorting to isolate germ cells at specific stages of development for analysis of HIPK4 expression and activity .

• Synchronization models: Use animal models with synchronized spermatogenesis (e.g., vitamin A-deficient mice followed by retinoic acid restoration) to obtain enriched populations of specific germ cell types.

• Single-cell RNA sequencing: This approach can provide high-resolution data on HIPK4 expression changes throughout spermatogenesis at the single-cell level.

• Temporal conditional knockout: Generate inducible knockout models where HIPK4 can be deleted at specific stages of spermatogenesis to determine the temporal requirements for its function.

• In situ hybridization: Use stage-specific markers alongside HIPK4 probes to precisely map expression patterns throughout spermatogenesis .

• Immunofluorescence with stage markers: Co-stain for HIPK4 and stage-specific markers of spermatogenesis in testis sections to create a detailed temporal map of expression .

• Phosphoproteomic time course: Perform phosphoproteomic analysis at different stages of spermatogenesis to identify temporal changes in HIPK4 substrate phosphorylation.